Progress Toward Polio Eradication-Worldwide, January 2020–April 2022
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index; 4 of the 26 sources its claims cite were checked for support.
Abstract
In 1988, the World Health Assembly established the Global Polio Eradication Initiative (GPEI). Since then, wild poliovirus (WPV) cases have decreased approximately 99.99%, and WPV types 2 and 3 have been declared eradicated. Only Afghanistan and Pakistan have never interrupted WPV type 1 (WPV1) transmission. This report describes global progress toward polio eradication during January 1, 2020-April 30, 2022, and updates previous reports (1,2). This activity was reviewed by CDC and was conducted consistent with applicable federal law and CDC policy.* Five WPV1 cases were reported from Afghanistan and Pakistan in 2021, compared with 140 in 2020. In 2022 (as of May 5), three WPV1 cases had been reported: one from Afghanistan and two from Pakistan. WPV1 genetically linked to virus circulating in Pakistan was identified in Malawi in a child with paralysis onset in November 2021. Circulating vaccine-derived polioviruses (cVDPVs), with neurovirulence and transmissibility similar to that of WPV, emerge in populations with low immunity following prolonged circulation of Sabin strain oral poliovirus vaccine (OPV) (3). During January 2020-April 30, 2022, a total of 1,856 paralytic cVDPV cases were reported globally: 1,113 in 2020 and 688 in 2021, including cases in Afghanistan and Pakistan. In 2022 (as of May 5), 55 cVDPV cases had been reported. Intensified programmatic actions leading to more effective outbreak responses are needed to stop cVDPV transmission. The 2022-2026 GPEI Strategic Plan objective of ending WPV1 transmission by the end of 2023 is attainable (4). However, the risk for children being paralyzed by polio remains until all polioviruses, including WPV and cVDPV, are eradicated.
Overview
CoChat Summary
TL;DR
This report updates global poliovirus eradication progress from January 2020 to April 2022, showing a sharp decline in WPV1 cases in Afghanistan and Pakistan in 2021 but continued transmission in both countries. It also documents substantial ongoing cVDPV2 activity and emphasizes that eradication progress must be sustained to prevent exportation and paralysis.
Key findings
- In 2021, only 5 WPV1 cases were reported globally, all from the two endemic countries: 4 in Afghanistan and 1 in Pakistan, compared with 140 in 2020.
- In 2022 (as of May 5), 3 WPV1 cases had been reported: 1 in Afghanistan and 2 in Pakistan.
- During January 2020–April 2022, a total of 1,856 paralytic cVDPV cases were reported globally; by serotype, 1,804 were cVDPV2, 51 were cVDPV1, and 1 was cVDPV3.
- Global cVDPV2 cases fell by 37.7% in 2021: 672 cases in 21 countries versus 1,079 cases in 24 countries in 2020.
Methods
- Descriptive global surveillance update using routine poliovirus program data from January 1, 2020–April 30, 2022.
- Data sources included AFP case-based syndromic surveillance, stool testing through the Global Polio Laboratory Network, and environmental surveillance of sewage samples.
- The report summarizes counts and proportions of cases, isolates, vaccine coverage, and surveillance indicators across countries and years; no formal inferential analysis is described.
Limitations
- The paper states that subnational AFP surveillance performance was highly variable, and that gaps often exist in poliovirus detection subnationally even when national targets are met.
- The text states that COVID-19 prevention efforts affected AFP surveillance sensitivity and routine immunization globally.
- Evident from the report format: it is a descriptive surveillance report, so it cannot by itself establish causality for the observed declines in WPV1 or cVDPV2 transmission.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
4 Valid · 0 Not valid · 19 Not checked · 39 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“Among the 43 priority countries, 32 (74%) met both surveillance indicator targets nationally in 2021.”
§ Progress Toward Polio Eradication — Worldwide, January 2020–April 2022 In 1988, the World Health Assembly established the Global Polio Eradication Initiative (GPEI). Since then, wild poliovirus (WPV) cases have decreased approximately 99.99%, and WPV types 2 and 3 have been declared eradicated. Only Afghanistan and Pakistan have never interrupted WPV type 1 (WPV1) transmission. This report describes global progress toward polio eradication during January 1, 2020–April 30, 2022, and updates previous reports (1,2). This activity was reviewed by CDC and was conducted consistent with applicable federal law and CDC policy.* Five WPV1 cases were reported from Afghanistan and Pakistan in 2021, compared with 140 in 2020. In 2022 (as of May 5), three WPV1 cases had been reported: one from Afghanistan and two from Pakistan. WPV1 genetically linked to virus circulating in Pakistan was identified in Malawi in a child with paralysis onset in November 2021. Circulating vaccine-derived polioviruses (cVDPVs), with neurovirulence and transmissibility similar to that of WPV, emerge in populations with low immunity following prolonged circulation of Sabin strain oral poliovirus vaccine (OPV) (3). During January 2020–April 30, 2022, a total of 1,856 paralytic cVDPV cases were reported globally: 1,113 in 2020 and 688 in 2021, including cases in Afghanistan and Pakistan. In 2022 (as of May 5), 55 cVDPV cases had been reported. Intensified programmatic actions leading to more effective outbreak responses are needed to stop cVDPV transmission. The 2022–2026 GPEI Strategic Plan objective of ending WPV1 transmission by the end of 2023 is attainable (4). However, the risk for children being paralyzed by polio remains until all polioviruses, including WPV and cVDPV, are eradicated. > Poliovirus Surveillance
What the sources say
- Supportedcites [7] Wilkinson, 2022, Surveillance to track progress toward polio eradication—worldwide, 2020–2021., MMWR Morb Mortal Wkly Rep source
The paper’s opening summary states that it assessed 43 priority countries and that, in 2021, 32 (74%) met both surveillance performance indicator targets nationally. This directly matches the claim. (LLM, conf=0.95)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Subnational performance was highly variable (7).”
§ Progress Toward Polio Eradication — Worldwide, January 2020–April 2022 In 1988, the World Health Assembly established the Global Polio Eradication Initiative (GPEI). Since then, wild poliovirus (WPV) cases have decreased approximately 99.99%, and WPV types 2 and 3 have been declared eradicated. Only Afghanistan and Pakistan have never interrupted WPV type 1 (WPV1) transmission. This report describes global progress toward polio eradication during January 1, 2020–April 30, 2022, and updates previous reports (1,2). This activity was reviewed by CDC and was conducted consistent with applicable federal law and CDC policy.* Five WPV1 cases were reported from Afghanistan and Pakistan in 2021, compared with 140 in 2020. In 2022 (as of May 5), three WPV1 cases had been reported: one from Afghanistan and two from Pakistan. WPV1 genetically linked to virus circulating in Pakistan was identified in Malawi in a child with paralysis onset in November 2021. Circulating vaccine-derived polioviruses (cVDPVs), with neurovirulence and transmissibility similar to that of WPV, emerge in populations with low immunity following prolonged circulation of Sabin strain oral poliovirus vaccine (OPV) (3). During January 2020–April 30, 2022, a total of 1,856 paralytic cVDPV cases were reported globally: 1,113 in 2020 and 688 in 2021, including cases in Afghanistan and Pakistan. In 2022 (as of May 5), 55 cVDPV cases had been reported. Intensified programmatic actions leading to more effective outbreak responses are needed to stop cVDPV transmission. The 2022–2026 GPEI Strategic Plan objective of ending WPV1 transmission by the end of 2023 is attainable (4). However, the risk for children being paralyzed by polio remains until all polioviruses, including WPV and cVDPV, are eradicated. > Poliovirus Surveillance
What the sources say
- Supportedcites [7] Wilkinson, 2022, Surveillance to track progress toward polio eradication—worldwide, 2020–2021., MMWR Morb Mortal Wkly Rep source
The Summary (p. 1) and 'What is added by this report?' state that 'substantial national and subnational gaps persist' despite 74% of priority countries meeting both national targets in 2021, and the Discussion (p. 5) notes 'Subnational surveillance gaps were apparent among one or more priority countries in each WHO region.' The Acute Flaccid Paralysis Surveillance section (pp. 3-4) documents the range underlying that variability: 75% of first subnational administrative level areas met both targets in AFR in 2021, most EMR countries performed well subnationally except Djibouti, Tajikistan improved significantly, while none of the subnational areas met both targets in Myanmar or Papua New Guinea and only 20.5% of the Philippine population lived in areas meeting both. 'Highly variable' is a fair paraphrase of this reported heterogeneity, within the source's scope of 43 priority countries in 2020-2021. (LLM, conf=0.85)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Whether or not AFP surveillance performance indicator targets are met, gaps often exist in poliovirus detection subnationally.”
§ Progress Toward Polio Eradication — Worldwide, January 2020–April 2022 In 1988, the World Health Assembly established the Global Polio Eradication Initiative (GPEI). Since then, wild poliovirus (WPV) cases have decreased approximately 99.99%, and WPV types 2 and 3 have been declared eradicated. Only Afghanistan and Pakistan have never interrupted WPV type 1 (WPV1) transmission. This report describes global progress toward polio eradication during January 1, 2020–April 30, 2022, and updates previous reports (1,2). This activity was reviewed by CDC and was conducted consistent with applicable federal law and CDC policy.* Five WPV1 cases were reported from Afghanistan and Pakistan in 2021, compared with 140 in 2020. In 2022 (as of May 5), three WPV1 cases had been reported: one from Afghanistan and two from Pakistan. WPV1 genetically linked to virus circulating in Pakistan was identified in Malawi in a child with paralysis onset in November 2021. Circulating vaccine-derived polioviruses (cVDPVs), with neurovirulence and transmissibility similar to that of WPV, emerge in populations with low immunity following prolonged circulation of Sabin strain oral poliovirus vaccine (OPV) (3). During January 2020–April 30, 2022, a total of 1,856 paralytic cVDPV cases were reported globally: 1,113 in 2020 and 688 in 2021, including cases in Afghanistan and Pakistan. In 2022 (as of May 5), 55 cVDPV cases had been reported. Intensified programmatic actions leading to more effective outbreak responses are needed to stop cVDPV transmission. The 2022–2026 GPEI Strategic Plan objective of ending WPV1 transmission by the end of 2023 is attainable (4). However, the risk for children being paralyzed by polio remains until all polioviruses, including WPV and cVDPV, are eradicated. > Poliovirus Surveillance
What the sources say
- Supportedcites [7] Wilkinson, 2022, Surveillance to track progress toward polio eradication—worldwide, 2020–2021., MMWR Morb Mortal Wkly Rep source
The Summary/Introduction (p. 1) states that although 32 (74%) of 43 priority countries met both key AFP surveillance performance indicator targets nationally in 2021 (up from 53% in 2020), 'substantial national and subnational gaps persist,' and the 'What is added by this report' box repeats this. The Discussion (p. 2) adds that 'Subnational surveillance gaps were apparent among one or more priority countries in each WHO region,' and the regional results give examples where national targets were met while subnational areas were not (EMR/Djibouti, SEAR/Myanmar, WPR/Philippines). The Discussion's limitation that high NPAFP rates do not necessarily indicate highly sensitive surveillance because some actual AFP cases might go undetected, together with the stated link between surveillance performance and 'the overall sensitivity and timelines of poliovirus detection,' supports the claim's framing of these gaps as gaps in poliovirus detection. (LLM, conf=0.85)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The single case reported from Balochistan province in Pakistan in 2021 represents a 99% decrease from 84 WPV1 cases in five provinces during 2020 (8).”
§ Progress Toward Polio Eradication — Worldwide, January 2020–April 2022 In 1988, the World Health Assembly established the Global Polio Eradication Initiative (GPEI). Since then, wild poliovirus (WPV) cases have decreased approximately 99.99%, and WPV types 2 and 3 have been declared eradicated. Only Afghanistan and Pakistan have never interrupted WPV type 1 (WPV1) transmission. This report describes global progress toward polio eradication during January 1, 2020–April 30, 2022, and updates previous reports (1,2). This activity was reviewed by CDC and was conducted consistent with applicable federal law and CDC policy.* Five WPV1 cases were reported from Afghanistan and Pakistan in 2021, compared with 140 in 2020. In 2022 (as of May 5), three WPV1 cases had been reported: one from Afghanistan and two from Pakistan. WPV1 genetically linked to virus circulating in Pakistan was identified in Malawi in a child with paralysis onset in November 2021. Circulating vaccine-derived polioviruses (cVDPVs), with neurovirulence and transmissibility similar to that of WPV, emerge in populations with low immunity following prolonged circulation of Sabin strain oral poliovirus vaccine (OPV) (3). During January 2020–April 30, 2022, a total of 1,856 paralytic cVDPV cases were reported globally: 1,113 in 2020 and 688 in 2021, including cases in Afghanistan and Pakistan. In 2022 (as of May 5), 55 cVDPV cases had been reported. Intensified programmatic actions leading to more effective outbreak responses are needed to stop cVDPV transmission. The 2022–2026 GPEI Strategic Plan objective of ending WPV1 transmission by the end of 2023 is attainable (4). However, the risk for children being paralyzed by polio remains until all polioviruses, including WPV and cVDPV, are eradicated. > Reported Poliovirus Cases and Isolations
What the sources say
- Partly supportedcites [8] Sadigh, 2022, Progress toward poliomyelitis eradication—Afghanistan, January 2020–November 2021., MMWR Morb Mortal Wkly Rep sourceExperimental — accuracy not yet measured
Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
plainn = 84- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
None of the sources cited for this claim have been checked yet.
In the paper
“In November 2020, the World Health Organization (WHO) granted Emergency Use Listing** for novel OPV2 (nOPV2), designed to be more genetically stable than the Sabin strain and less likely to revert to neurovirulence (6).”
§ Progress Toward Polio Eradication — Worldwide, January 2020–April 2022 In 1988, the World Health Assembly established the Global Polio Eradication Initiative (GPEI). Since then, wild poliovirus (WPV) cases have decreased approximately 99.99%, and WPV types 2 and 3 have been declared eradicated. Only Afghanistan and Pakistan have never interrupted WPV type 1 (WPV1) transmission. This report describes global progress toward polio eradication during January 1, 2020–April 30, 2022, and updates previous reports (1,2). This activity was reviewed by CDC and was conducted consistent with applicable federal law and CDC policy.* Five WPV1 cases were reported from Afghanistan and Pakistan in 2021, compared with 140 in 2020. In 2022 (as of May 5), three WPV1 cases had been reported: one from Afghanistan and two from Pakistan. WPV1 genetically linked to virus circulating in Pakistan was identified in Malawi in a child with paralysis onset in November 2021. Circulating vaccine-derived polioviruses (cVDPVs), with neurovirulence and transmissibility similar to that of WPV, emerge in populations with low immunity following prolonged circulation of Sabin strain oral poliovirus vaccine (OPV) (3). During January 2020–April 30, 2022, a total of 1,856 paralytic cVDPV cases were reported globally: 1,113 in 2020 and 688 in 2021, including cases in Afghanistan and Pakistan. In 2022 (as of May 5), 55 cVDPV cases had been reported. Intensified programmatic actions leading to more effective outbreak responses are needed to stop cVDPV transmission. The 2022–2026 GPEI Strategic Plan objective of ending WPV1 transmission by the end of 2023 is attainable (4). However, the risk for children being paralyzed by polio remains until all polioviruses, including WPV and cVDPV, are eradicated. > Poliovirus Vaccination
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
38 more claims
Create a free account to see all 62 claims and to verify the 22 references still open.
- It may state two separate claims as one. 14
- Probably not a substantial claim. 5
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“As a result of its efforts, progress has been impressive: the number of paralytic polio cases worldwide has been reduced by more than 99%, and the number of countries where the disease is endemic has fallen dramatically [59].”
From The Fight against Poliovirus Is Not Over (2023) · cites this paper as [59]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In 2021, five cases of WPV1 were reported in these two countries, which represents a significant decrease compared to the previous year.”
From The Fight against Poliovirus Is Not Over (2023) · cites this paper as [59]
Citations
Cites
Global polio eradication initiative
Koenig‐Archibugi, M. (2011) · London School of Economics and Political Science Research Online (London School of Economics and Political Science) · Cited by 523
Progress toward polio eradication—worldwide, January 2018–March 2020.
Chard, A. N., Datta, S. D., Tallis, G., Burns, C. C., Wassilak, S. G. F., Vertefeuille, J. F., & Zaffran, M. (2020) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6925a4 · Cited by 83
Self-citationProgress toward polio eradication—worldwide, January 2019–June 2021.
Bigouette, J. P., Wilkinson, A. L., Tallis, G., Burns, C. C., Wassilak, S. G. F., & Vertefeuille, J. F. (2021) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm7034a1 · Cited by 62
Self-citationUpdate on Vaccine-Derived Poliovirus Outbreaks — Worldwide, January 2020–June 2021
Alleman, M. M., Jorba, J., Henderson, E., Diop, O. M., Shaukat, S., Traoré, M. A., Wiesen, E., Wassilak, S. G. F., & Burns, C. C. (2021) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm7049a1 · Cited by 62
Self-citationSurveillance to Track Progress Toward Polio Eradication — Worldwide, 2017–2018
Patel, J. C., Diop, O. M., Gardner, T., Chavan, S., Jorba, J., Wassilak, S. G. F., Ahmed, J., & Snider, C. J. (2019) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6813a4 · Cited by 48
Self-citationSurveillance to track progress toward polio eradication—worldwide, 2020–2021.
Wilkinson, A. L., Diop, O. M., Jorba, J., Gardner, T., Snider, C. J., & Ahmed, J. (2022) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm7115a2 · Cited by 30
Self-citationProgress toward poliomyelitis eradication—Afghanistan, January 2020–November 2021.
Sadigh, K. S., Akbar, I. E., Wadood, M. Z., Shukla, H., Jorba, J., Chaudhury, S., & Martinez, M. (2022) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm7103a3 · Cited by 21
Self-citation
Cited by
Progress Toward Poliomyelitis Eradication — Worldwide, January 2021–March 2023
Lee, S. E., Greene, S. A., Burns, C. C., Tallis, G. F., Wassilak, S. G. F., & Bolu, O. O. (2023) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm7219a3 · Cited by 63
“This report summarizes progress toward global polio eradication during January 1, 2021–March 31, 2023, and updates previous reports (1,2).”
BackgroundInfluentialSelf-citationOpportunities and challenges for T cell-based influenza vaccines
Mosmann, T. R., McMichael, A. J., LeVert, A., McCauley, J. W., & Almond, J. W. (2024) · Nature reviews. Immunology · doi:10.1038/s41577-024-01030-8 · Cited by 57
“…the polio, measles, rubella, mumps and hepa titis A vaccines, can also be far more effective than those against influenza, and even provide the basis for future eradication of polio 41 , rubella and measles 42,43 (Measles & Rubella Partnership, WHO: Measles, Polio Global Eradication Initiative).”
Update on Vaccine-Derived Poliovirus Outbreaks — Worldwide, January 2021–December 2022
Bigouette, J. P., Henderson, E., Traore, M. A., Wassilak, S. G. F., Jorba, J. C., Mahoney, F. J., Bolu, O. O., Diop, O. M., & Burns, C. C. (2023) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm7214a3 · Cited by 55
Self-citationPoliomyelitis is a current challenge: long-term sequelae and circulating vaccine-derived poliovirus
Quarleri, J. F. (2022) · GeroScience · doi:10.1007/s11357-022-00672-7 · Cited by 46
Progress Toward Poliomyelitis Eradication — Worldwide, January 2022–December 2023
Geiger, K., Stehling-Ariza, T., Bigouette, J. P., Bennett, S. D., Burns, C. C., Quddus, A., Wassilak, S. G. F., & Bolu, O. O. (2024) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm7319a4 · Cited by 44
“This report summarizes the status of polio eradication during January 1, 2022–December 31, 2023, and updates previous reports ( 1 , 6 ).”
BackgroundSelf-citation
Metadata
- Authors
- Rachlin, A., Patel, J. C., Burns, C. C., Jorba, J., Tallis, G., O’Leary, A., Wassilak, S. G. F., & Vertefeuille, J. F.
- Affiliations
- National Center for Immunization and Respiratory Diseases (US)
- Corresponding author
- Rachlin, Audrey
- ORCID
- Venue
- MMWR Morbidity and Mortality Weekly Report
- Published
- 2022-05-13
- Volume
- 71
- Issue
- 19
- Pages
- 650-655
- ISSN
- 0149-2195 (ISSN-L)
- 1545-861X
- PMC
- PMC9098249
- OpenAlex
- W4280493380
- Cited by
- 61
- References
- 7
- Citations by year
- 2026: 5 · 2025: 9 · 2024: 11 · 2023: 23 · 2022: 13
- FWCI
- 9.75
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Locations
- MMWR Morbidity and Mortality Weekly Report (publishedVersion)
- PubMed Central (publishedVersion, public-domain)
- PubMed (publishedVersion)
- Funders
- World Health Organization
- Centers for Disease Control and Prevention
- National Center for Immunization and Respiratory Diseases
- Topics
- Health Sciences › Medicine › Infectious Diseases › Viral Infections and Immunology Research
- Social Sciences › Health › Vaccine Coverage and Hesitancy
- Health Sciences › Medicine › Epidemiology › Virology and Viral Diseases
- Keywords
- polio eradication, wild poliovirus type 1, circulating vaccine-derived poliovirus, oral polio vaccine, Global Polio Eradication Initiative, Afghanistan, Pakistan, Malawi, paralysis, vaccination coverage
- MeSH terms
- Child, Humans, Poliomyelitis, Poliovirus Vaccine, Oral, Population Surveillance, Immunization Programs, Poliovirus, Disease Eradication
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Progress Toward Polio Eradication-Worldwide, January 2020–April 2022. https://app.cochat.ai/papers/10.15585/mmwr.mm7119a2
- The paper
- Rachlin, A., Patel, J. C., Burns, C. C., Jorba, J., Tallis, G., O’Leary, A., Wassilak, S. G. F., & Vertefeuille, J. F. (2022). Progress Toward Polio Eradication-Worldwide, January 2020–April 2022. MMWR Morbidity and Mortality Weekly Report. https://doi.org/10.15585/mmwr.mm7119a2
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
